Skip to content

Ayurvedic management of menstrual irregularity

A single arm clinical trial to evaluate the effect of Koshtashodhana and Haridradigana ghana vati in the management of Artavadosha associated with Non-Hyperandrogenic Polycystic Ovary Syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079442
Enrollment
40
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

Dr Sulekha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married and unmarried females willing to take part in study BMI more than or equal to 18.5 kg/m2 to less than or equal to 35kg/m2 Interval of menstrual cycles- 38 to 90 days in the past 2 cycles or less than 9 menstrual periods in one year Already diagnosed and newly diagnosed patients of PCOS with phenotype D (non –hyperandrogenic PCOS) Patients who have informed written consent

Exclusion criteria

Exclusion criteria: Subjects with Hyperthyroidism and uncontrolled hypothyroidism Subjects taking any hormonal medication from last three months at the time of screening Subjects with Hyperprolactinemia having Serum Prolactin more than 30 ng/ml Subjects with Hyperandrogenism Serum Testosterone level more than 0.6ng/ml Subjects with Modified Ferriman Gallway Score more than 8 Subjects having uncontrolled hypertension BP more than 130/90mmHg and DM II FBS more than 150mg/dl Subjects suffering from any kind of congenital disease for example congenital adrenal hyperplasia Subjects having any pelvic pathologies like androgen secreting tumours uterine fibroid endometriosis adenomyosis pelvic inflammatory diseases etc Pregnant lactating women

Design outcomes

Primary

MeasureTime frame
Reduction in inter-menstrual intervalTimepoint: baseline to 90th day

Secondary

MeasureTime frame
Reduction in ovarian volume Reduction in no. of cysts in ovary Decrease in Fasting blood sugar levelTimepoint: Baseline to 90th day

Countries

India

Contacts

Public ContactDr Archana S

Shri Dhanwantry Ayurvedic college and Hospital Sec 46B Chandigarh

archanas875@gmail.com9447767909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026